You are here: All Products  > Genor Reports CDK4/6 Inhibitor NDA Under Review in China for Breast Cancer

Genor Reports CDK4/6 Inhibitor NDA Under Review in China for Breast Cancer

Price: $5.00
Available

Get instant access to this article for unlimited viewing and/or downloading for seven days.


Back to products